ENTA

ENANTA PHARMACEUTICALS INC

Biotechnology · Biotechnology

$276.82 sample

+0.17 (+0.06%) 1D

Market cap

$1.45T

Price as of

2026-10-03

Latest filing

8-K · 2026-09-21

Alerts

8

Price$276.82 +9.95% 3M daily closessample

285.98250.53

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 30INSInsider buy: EVP, Operations
Sep 21SECDEF 14A filed
Sep 15INSInsider sell: Chief Executive Officer
Sep 04SECForm 144 filed
Aug 31INSInsider sell: General Counsel
Aug 21SECDEF 14A filed
Aug 14INSInsider buy: Director
Aug 05INSInsider sell: Director

Sign up to see the real ENTA record →

Company facts

SEC EDGAR registration

Name: ENANTA PHARMACEUTICALS INC
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: -59sample, -100 to +100
Reporting currency: USD

Who is positioning in ENTA

sample

Insiders: 32 insider transactions over 90 days, net selling, $433.6M
Congress: 5 members traded over 90 days
Institutions · 13F: 39 funds hold $25.9B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$55.0B +16.5% y/y

Q4 2024Q3 2026

Inventory$32.6B +11.9% y/y

Q4 2024Q3 2026

Accounts receivable$23.7B +12.8% y/y

Q4 2024Q3 2026

Total debt$64.2B +13.6% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $1.20T -5.9% 3M
Sample peer B: $1.30T -2.1% 3M
Sample peer C: $340.0B -3.8% 3M
Sample peer D: $1.24T +13.2% 3M
Sample peer E: $880.6B -8.6% 3M